AI assistant
Sending…
ArcticZymes Technologies — Director's Dealing 2010
Mar 10, 2010
3538_dirs_2010-03-10_2ca56ee4-68e5-4117-9b82-996bd7799b5f.html
Director's Dealing
Open in viewerOpens in your device viewer
Meldepliktig handel
Nytilsatt administrerende direktør Svein Lien har via
sitt heleide selskap Spiralen Industier AS i dag
kjøpt 72.000 aksjer i Biotec Pharmacon ASA til en
gjennomsnittskurs kr 6,23. Etter dette kjøpet eier
Spiralen Industrier AS 103.000 aksjer i selskapet.
Svein Lien eier ingen aksjer privat i Biotec
Pharmacon.
More from ArcticZymes Technologies
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Interim / Quarterly Report
2026
May 7
Call Transcript
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
May 6
AGM Information
2026
May 6
Investor Presentation
2026
May 4
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30